NDC 0093-9222
Diflunisal
Diflunisal
Diflunisal is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Diflunisal.
| Product ID | 0093-9222_8b62b5af-d2a9-4d06-a78b-23f92523c19f |
| NDC | 0093-9222 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Diflunisal |
| Generic Name | Diflunisal |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-06-30 |
| Marketing Category | ANDA / |
| Application Number | ANDA073673 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | DIFLUNISAL |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |